Citations

Showing 10 of 108135 citations.

Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldenstrom Macroglobulinemia
Kaushal, Akhilesh , Carr, Allison R. , Pendleton, Katherine E. , Barwick, Benjamin G. , Manalo, Renee Julia , McCachren, Samuel S. , Gupta, Vikas A. , Joseph, Nisha S. , Hofmeister, Craig C. , Heffner, Leonard T., Ansell, Stephen M. , Dhodapkar, Kavita M. , Dhodapkar, Madhav V. , Pendleton, Katherine E , Barwick, Benjamin G , Manalo, Julia , McCachren, Samuel S , Gupta, Vikas A , Hofmeister, Craig C , Kaufman, Jonathan L , Ansell, Stephen M , Boise, Lawrence H , Dhodapkar, Kavita M , Nooka, Ajay K. , Kaufman, Jonathan L. , Boise, Lawrence , Lonial, Sagar

Mayo Clinic

Blood Cancer Discovery | September 1, 2021 | Volume: 2 | Issue: 6 | Pages: 600-615

10.1158/2643-3230.bcd-21-0043 | PMID 34778800 Get It

Abstract Waldenstrom macroglobulinemia (WM) and its precursor IgM gammopathy are distinct disorders characterized by clonal mature IgM-expressing B-cell outgrowth in the bone marrow. Here, we show by high-dimensional single-cell immunogenomic profiling of patient samples that these disorders originate in the setting of global B-cell compartment alterations, characterized by expansion of genomically aberrant extrafollicular B cells of the nonmalignant clonotype. Alterations in the immune microenvironment preceding malignant clonal expansion include myeloid inflammation and naïve B- and T-cell depletion. Host response to these early lesions involves clone-specific T-cell immunity that may include MYD88 mutation–specific responses. Hematopoietic progenitors carry the oncogenic MYD88 mutations characteristic of the malignant WM clone. These data support a model for WM pathogenesis wherein oncogenic alterations and signaling in progenitors, myeloid inflammation, and global alterations in extrafollicular B cells create the milieu promoting extranodal pattern of growth in differentiated malignant cells. Significance: These data provide evidence that growth of the malignant clone in WM is preceded by expansion of extrafollicular B cells, myeloid inflammation, and immune dysfunction in the preneoplastic phase. These changes may be related in part to MYD88 oncogenic signaling in pre–B progenitor cells and suggest a novel model for WM pathogenesis. This article is highlighted in the In This Issue feature, p. 549
Favorable Early Outcomes With Thyroid Lobectomy for Low-Risk Papillary Thyroid Cancer: The Mayo Clinic Experience
Merten, Michele M., Foster, Trenton R. , Lyden, Melanie L. , Henry, Michael , Castro, M. Regina , Foster, Trenton, Lyden, Melanie, Henry, Michael

Mayo Clinic

The American Surgeon™ | September 1, 2021 | Volume: 87 | Issue: 9 | Pages: 1374-1378

10.1177/00031348211038557 | PMID 34468234 Get It

Background Until 2015, standard of care for low-risk papillary thyroid cancer (PTC) >1 cm was a total or near-total thyroidectomy. Despite changes in guidelines and surgical management of low-risk PTC since 2015, little data are available regarding the effect on the need for additional surgery or risk for development of lymph node metastases. Our aim was to determine outcomes in patients who underwent initial thyroid lobectomy for low-risk PTC at a high-volume tertiary care institution. Methods Retrospective review of patients ≥18 years old with biopsy proven low-risk PTC 1-4 cm who underwent partial thyroidectomy (eg, lobectomy/isthmusectomy) at Mayo Clinic, Rochester, MN, between March 2016 and June 30, 2019. Results From 1481 thyroidectomies performed during study period, 940 contained PTC on final pathology. Of these, 87 (of 123) patients who had an initial thyroid lobectomy met inclusion criteria. Five (6%) of these patients proceeded to completion thyroidectomy (CT), with 3 requiring CT and radioactive iodine in the first postoperative year and 2 undergoing only CT in the second postoperative year. No postoperative complications were reported. No patient in this cohort required additional surgery or treatment for newly discovered lymph node metastases during the follow-up period. 43 (of 72, 60%) patients not on thyroxine therapy preoperatively were started on thyroxine therapy postoperatively. Conclusions Early outcomes for those undergoing thyroid lobectomy for low-risk PTC at our institution have been favorable. These results support the 2015 American Thyroid Association guidelines to offer lobectomy for those with low-risk PTC 1-4 cm.
Association of Local Therapy With Quality-of-Life Outcomes in Young Women With Breast Cancer
Dominici, Laura S. , Hu, Jiani , Kim, Hee Jeong , King, Tari A. , Ruddy, Kathryn J. , Peppercorn, Jeffrey , Schapira, Lidia , Come, Steven E. , Wong, Julia S., Rosenberg, Shoshana M. , Zheng, Yue , Tamimi, Rulla M. , Borges, Virginia F. , Warner, Ellen , Partridge, Ann H.

Mayo Clinic

JAMA Surgery | September 1, 2021 | Volume: 156 | Issue: 10 | Pages: e213758

10.1001/jamasurg.2021.3758 | PMID 34468718 Get It

Incorporation of Social Risk in US Preventive Services Task Force Recommendations and Identification of Key Challenges for Primary Care
Davidson, Karina W. , Krist, Alex H. , Tseng, Chien‐Wen , Kemper, Alex R. , Kubik, Martha , Ngo‐Metzger, Quyen, Mills, Justin, Doubeni, Chyke A. , Krist, Alex , Davidson, Karina , Simon, Melissa Andrea , Borsky, Amanda E.

Mayo Clinic

JAMA | September 1, 2021 | Volume: 326 | Issue: 14 | Pages: 1410

10.1001/jama.2021.12833 | PMID 34468692 Get It

Advancing Women to Leadership Positions Through Individual Actions and Institutional Reform
Alli, Adebisi , Lin, Tammy , Thorndyke, Luanne E. , Parekh, Ranna, Núñez, Ana E.

Mayo Clinic

Pediatrics | September 1, 2021 | Volume: 148 | Issue: Supplement 2 | Pages: No page available

10.1542/peds.2021-051440d | PMID 34470879 Get It

In this case-based guide, we offer strategies and solutions for advancing women leaders, including tackling career transitions; we highlight individual actions and achievable institutional reforms. Women in medicine experience disparities in the workplace and in achieving leadership roles. They face challenges related to climate and culture, equitable compensation, work-life integration, opportunities for professional development and advancement, and occupational and systemic factors that can lead to burnout. Without specific resources to support women’s development and advancement and promote conducive workplace climates, efforts to recruit, retain, and promote women physicians into leadership roles may be futile. This article is designed for 2 audiences: women physicians of all career stages, who are exploring factors that may adversely impact their advancement opportunities, and leaders in academic medicine and health care, who seek to achieve inclusive excellence by fully engaging talent. The need for greater representation of women leaders in medicine is both a moral and a business imperative that requires systemic changes. Individuals and institutional leaders can apply the practical strategies and solutions presented to catalyze successful recruitment, retention, and promotion of women leaders and widespread institutional reform.
Psychometric Evaluation of the Kansas City Cardiomyopathy Questionnaire in Men and Women With Heart Failure
Hejjaji, Vittal , Coles, Theresa , Jones, Philip G. , Reeve, Bryce B. , Mentz, Robert J. , Spatz, Erica S. , Caldwell, Brittany, Saha, Anindita , Tarver, Michelle E. , Tran, Andy T , Patel, Krishna , Henke, Debra M. , Spertus, John A. , Coles, Theresa , Jones, Philip G , Reeve, Bryce B. , Spatz, Erica S , Dunlay, Shannon M. , Saha, Anindita , Patel, Krishna K , Spertus, John A , Mentz, Robert J , Tang, Yuanyuan , Piña, Ileana L.

Mayo Clinic

Circulation: Heart Failure | September 1, 2021 | Volume: 14 | Issue: 9 | Pages: No page available

10.1161/circheartfailure.120.008284 | PMID 34465123 Get It

Background: The Kansas City Cardiomyopathy Questionnaire (KCCQ) has been psychometrically evaluated in multiple heart failure (HF) populations, but the comparability of its psychometric properties between men and women is unknown. Methods: Data from 3 clinical trials (1 in stable HF with preserved ejection fraction, 1 each in stable and acute HF with reduced ejection fraction) and 1 prospective cohort study (stable HF with reduced ejection fraction), incorporating 6773 men and 3612 women with HF, were used to compare the construct validity, internal and test-retest reliability, ability to detect change, predict mortality and hospitalizations and minimally important differences between the 2 sexes. Interactions of the KCCQ overall summary and subdomain scores by sex were independently examined. Results: The KCCQ-Overall Summary score correlated well with New York Heart Association functional class in both sexes across patients with stable (correlation coefficient: −0.40 in men versus −0.49 in women) and acute (−0.37 in men versus −0.34 in women) HF. All KCCQ subdomains demonstrated concordant relationships with relevant comparison standards with no significant interactions by sex in 19 of 21 of these construct validity analyses. All KCCQ scores were equally predictive and other psychometric evaluations showed similar results by sex: test-retest reliability (intraclass correlation coefficient 0.94 in men versus 0.92 in women), responsive to change (standardized response mean 1.01 in both sexes), as were the minimally important differences and internal reliability. Conclusions: The psychometric properties of the KCCQ, in terms of validity, prognosis, reliability, and sensitivity to change, are comparable in men and women with HF with preserved ejection fraction and HF with reduced ejection fraction.
Introduction. Translational research advances in the evaluation and management of moyamoya disease
Smith, Edward R. , Steinberg, Gary K. , Xu, Bin , Steinberg, Gary K , Smith, Edward , Lanzino, Giuseppe

Mayo Clinic

Neurosurgical Focus | September 1, 2021 | Volume: 51 | Issue: 3 | Pages: E1

10.3171/2021.6.focus21373 | PMID 34469864 Get It

Assessing hip fracture risk in type-2 diabetic patients using CT-based autonomous finite element methods
Rotman, Dani , Ariel, Gal, Liévano, Jorge Rojas , Schermann, Haggai , Trabelsi, Nir, Salai, Moshe , Sternheim, Amir , Rojas Lievano, Jorge, Yosibash, Zohar , Lievano, Jorge Rojas

Mayo Clinic

The Bone & Joint Journal | September 1, 2021 | Volume: 103-B | Issue: 9 | Pages: 1497-1504

10.1302/0301-620x.103b9.bjj-2020-2147.r1 | PMID 34465153 Get It

AimsType 2 diabetes mellitus (T2DM) impairs bone strength and is a significant risk factor for hip fracture, yet currently there is no reliable tool to assess this risk. Most risk stratification methods rely on bone mineral density, which is not impaired by diabetes, rendering current tests ineffective. CT-based finite element analysis (CTFEA) calculates the mechanical response of bone to load and uses the yield strain, which is reduced in T2DM patients, to measure bone strength. The purpose of this feasibility study was to examine whether CTFEA could be used to assess the hip fracture risk for T2DM patients.MethodsA retrospective cohort study was undertaken using autonomous CTFEA performed on existing abdominal or pelvic CT data comparing two groups of T2DM patients: a study group of 27 patients who had sustained a hip fracture within the year following the CT scan and a control group of 24 patients who did not have a hip fracture within one year. The main outcome of the CTFEA is a novel measure of hip bone strength termed the Hip Strength Score (HSS).ResultsThe HSS was significantly lower in the study group (1.76 (SD 0.46)) than in the control group (2.31 (SD 0.74); p = 0.002). A multivariate model showed the odds of having a hip fracture were 17 times greater in patients who had an HSS ≤ 2.2. The CTFEA has a sensitivity of 89%, a specificity of 76%, and an area under the curve of 0.90.ConclusionThis preliminary study demonstrates the feasibility of using a CTFEA-based bone strength parameter to assess hip fracture risk in a population of T2DM patients. Cite this article: Bone Joint J 2021;103-B(9):1497–1504.
Characterizing Medicare Reimbursements and Clinical Activity Among Female Otolaryngologists
Panth, Neelima , Torabi, Sina J. , Kasle, David A. , Savoca, Emily L. , Zogg, Cheryl K. , O’Brien, Erin K. , Manes, R. Peter , O'Brien, Erin K

Mayo Clinic

Annals of Otology, Rhinology & Laryngology | September 1, 2021 | Volume: 131 | Issue: 7 | Pages: 749-759

10.1177/00034894211042445 | PMID 34467771 Get It

Objective: To evaluate geographic and temporal trends in Medicare fee-for-service (FFS) billing and reimbursements across female otolaryngologists (ORL). Methods: We performed a cross-sectional, retrospective analysis of the 2017 Medicare Physician and Other Suppliers Aggregate File. We analyzed differences in the number of services, patients, reimbursements, unique Current Procedural Terminology (CPT) codes used, and services billed per patient among female ORLs. Results: Female ORLs accounted for 15.2% of the 8453 Medicare-reimbursed ORLs. Female ORLs who graduated between 2000 and 2010 were reimbursed a median of $58 031.9 (IQR: $32 286.5-$91 512.2) and performed a median of 702 (IQR: 359.5-1221.5) services, significantly less than those who graduated between 1990 and 1999 (median: $67 508.9; IQR: 37 018.0-110 471.5; P < .001; median: 1055.5; IQR: 497.3-1944; P < .001). Female ORLs who graduated between 2000 and 2010 saw a median of 232 patients (IQR: 130.5-368), significantly less than those who graduated between 1990 and 1999 (median: 308; IQR: 168.3-496; P < .001) patients, significantly more than those. Female ORLs in urban settings performed a median of 795 (IQR: 364-1494.3) services and billed for a median of 42 (IQR: 28-58) unique codes, significantly fewer than their counterparts in rural settings (median: 1096; IQR: 600-2192.5; P = .002; median: 54; IQR: 31.5-64.5; P = .001). Conclusions: Medicare reimbursements and billing patterns across female ORLs varied by graduation decade and geography. Female ORLs further along in their careers may be reimbursed more with greater clinical volume and productivity. Those practicing in urban settings may have practices with decreased procedural diversity and lower clinical volume compared to their counterparts in rural areas.
Author Reply to “Regarding ‘The Top 50 Most‐Cited Shoulder Arthroscopy Studies’”
McQuivey, Kade S. , Bingham, Joshua S. , Moore, M. Lane , Pollock, Jordan Riley

Mayo Clinic

Arthroscopy | September 1, 2021 | Volume: 37 | Issue: 9 | Pages: 2730-2731

10.1016/j.arthro.2021.07.002 | PMID 34481614 Get It